NOTARFRANCHI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 182
EU - Europa 158
AS - Asia 29
AF - Africa 2
OC - Oceania 1
Totale 372
Nazione #
US - Stati Uniti d'America 179
IE - Irlanda 47
SE - Svezia 38
IT - Italia 36
CN - Cina 20
AT - Austria 13
DE - Germania 7
FI - Finlandia 4
RU - Federazione Russa 4
SG - Singapore 4
CA - Canada 3
FR - Francia 3
IN - India 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GB - Regno Unito 1
IR - Iran 1
LU - Lussemburgo 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
Totale 372
Città #
Chandler 63
Dublin 47
Ashburn 13
Parma 11
Vienna 10
Shanghai 9
New York 8
Ann Arbor 6
Beijing 6
Bremen 6
Princeton 6
Fairfield 5
San Mateo 4
Bologna 3
Cesena 3
Des Moines 3
Helsinki 3
Reggio Emilia 3
Fremont 2
Kocaeli 2
Norwalk 2
Ottawa 2
Palermo 2
Piacenza 2
Pune 2
Seattle 2
Shenyang 2
Wilmington 2
Augusta 1
Castel San Giovanni 1
Catania 1
Charlotte 1
Dallas 1
Denver 1
Focsani 1
Gatchina 1
Hangzhou 1
Lagos 1
Leawood 1
London 1
Lurate Caccivio 1
Milan 1
Montesilvano 1
Moscow 1
Naples 1
Nerviano 1
Phoenix 1
Rome 1
Sabz 1
Sofia 1
Sydney 1
Tampa 1
Toronto 1
Turku 1
Waltham 1
Washington 1
Totale 257
Nome #
Application of next-generation sequencing for the genomic characterization of patients with smoldering myeloma 88
PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients 64
Concomitant primary hyperparathyroidism in patients with multiple myeloma: A possible link? 50
Combining bortezomib to high dose melphalan as conditioning regimen results in the improvement of the response rate in newly diagnosed young multiple myeloma patients 50
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma 48
Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results 44
The impact of CD56 expression in smoldering myeloma patients on early progression 28
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 17
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 2
Totale 391
Categoria #
all - tutte 1.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.555


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 2 1 0 0
2020/202148 13 0 1 1 4 0 1 5 2 10 5 6
2021/202251 0 4 3 2 0 0 11 5 1 2 0 23
2022/2023217 22 24 18 19 10 22 10 13 57 6 8 8
2023/202472 4 7 1 5 9 25 14 2 5 0 0 0
Totale 391